Ad
related to: statistically significant
Search results
Much-maligned umpire Ángel Hernández to retire from Major League Baseball
USA TODAY Sports via Yahoo Sports· 3 days agoDistrict Court in 2021, granting MLB a summary judgement. The 2nd Circuit U.S. Court of Appeals...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAn independent Data Monitoring Committee conducted an interim analysis that revealed a statistically...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KOLR - KSFX Ozarks· 6 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European ...
Reform won’t recover from this false start
The Telegraph via Yahoo News· 16 hours agoFour weeks ago we found out Reform UK was real. Though it did not stand candidates everywhere in the local elections, where it did it performed well. In...
Summit Therapeutics cancer therapy succeeds in late-stage China study
Reuters· 5 hours ago, opens new tab said on Thursday its experimental therapy to treat patients with a type of lung cancer met the main goal of a late-stage study conducted in China, sending its shares soaring ...
Poll suggests fighting Ottawa is a political winner for Danielle Smith and the UCP
CBC via Yahoo News· 2 days agoEDITOR'S NOTE: CBC News commissioned this public opinion research in April, leading into the first...
Insmed shares skyrocket on positive trial results for lung drug By Proactive Investors
Investing.com· 2 days agoThe company said patients in the study with non-cystic fibrosis bronchiectasis who were dosed with...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga· 2 days agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
Zacks· 20 hours agoFree Report) announced that the European Commission (EC) has approved its blockbuster immuno-oncology drug, Opdivo (nivolumab), in combination with a chemotherapy combination, cisplatin and ...
Neuren Pharmaceuticals’ NNZ-2591 shows promise in trial for Pitt Hopkins syndrome
Clinical Trials Arena via Yahoo Finance· 3 days agoSafety, tolerability and pharmacokinetics were the trial's primary endpoints, while its secondary...
